Is it appropriate to increase mirtazapine to 15 mg for two nights and then revert to 7.5 mg on the third night as per the doctor's order?

This Dosing Schedule is Not Appropriate

The prescribed regimen of increasing mirtazapine to 15 mg for two nights and then reverting to 7.5 mg on the third night contradicts FDA-approved dosing guidelines and lacks clinical rationale. According to the FDA label, mirtazapine should be started at 15 mg once daily (preferably at bedtime), and dose changes should not be made in intervals of less than 1 to 2 weeks to allow sufficient time for evaluation of response 1. This rapid dose fluctuation serves no therapeutic purpose and may increase side effects without clinical benefit.

Why This Regimen is Problematic

The FDA-approved dosing strategy is clear: start at 15 mg daily and maintain this dose for at least 1-2 weeks before considering any adjustment 1. The rationale behind this timeline is pharmacokinetic—mirtazapine has a half-life of 20-40 hours, meaning steady-state concentrations are not achieved until approximately 5 half-lives (roughly 5-10 days) 1.

Rapidly cycling between 15 mg and 7.5 mg prevents achievement of steady-state plasma concentrations, making it impossible to assess true therapeutic response or tolerability. This approach essentially restarts the titration process every few days, which is pharmacologically unsound.

Evidence-Based Dosing Recommendations

Standard Initiation Protocol

• Start at 15 mg once daily at bedtime 1
• Maintain this dose for a minimum of 1-2 weeks 1
• If inadequate response after this period, increase to 30 mg daily 1
• Maximum dose is 45 mg daily 1

Alternative Low-Dose Start (If Sedation is a Concern)

If there are specific concerns about initial sedation or tolerability, some evidence supports starting at 7.5 mg:

• Begin with 7.5 mg nightly 2, 3
• Research shows 7.5 mg causes less driving impairment and daytime somnolence compared to 15 mg 3
• After 7-14 days at 7.5 mg, increase to 15 mg if tolerated 2
• Continue at 15 mg for at least 1-2 weeks before further dose adjustments 1

A 2024 study in hemodialysis patients successfully used 7.5 mg for the first two nights, then increased to 15 mg and maintained that dose for the remainder of the 2-week treatment period 2. This demonstrates that if a lower starting dose is used, the increase should be sustained, not reversed.

Clinical Considerations

Sedation is typically transient: Research indicates that sedative effects of mirtazapine are most prominent in the first week and tend to diminish with continued use 4. Plasma concentration monitoring shows that while there's a correlation between concentration and sedation in week 1, this relationship disappears with longer treatment duration 4.

The 7.5 mg dose may be subtherapeutic: Evidence suggests a threshold plasma concentration of approximately 30 ng/mL is needed for antidepressant response 4. Lower doses may not achieve this concentration in many patients.

Dose-response relationship: A 2015 study found that patients who failed to improve on 15 mg showed significantly better outcomes when increased to 30 mg compared to those who remained at 15 mg 5. This supports maintaining adequate dosing rather than reducing doses prematurely.

Recommended Correction

Contact the prescribing physician to clarify the intended regimen. The appropriate approach should be either:

1. If starting fresh: Begin 15 mg nightly and maintain for 1-2 weeks minimum 1

2. If sedation is a major concern: Start 7.5 mg nightly for 7-14 days, then increase to 15 mg and maintain 2, 3

3. Never alternate doses on a 2-day cycle—this has no pharmacological basis and will not allow proper assessment of efficacy or tolerability

The current order may represent a prescribing error or miscommunication and should be verified before implementation.